Evidence map›Paper›PMID 34373245›Full record

ArticleBMJ case reports2021

Hashimoto's thyroiditis following SARS-CoV-2 infection.

Rafael Silvestre Knack, Taliê Hanada, Renata Silvestre Knack, Kamilla Mayr

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Systematic review of COVID-19 and autoimmune thyroiditis.Travel medicine and infectious disease
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Thyroid Autoimmunity and SARS-CoV-2 Infection.Journal of clinical medicine · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. COVID-19 and chronic fatigue syndrome: An endocrine perspective.Journal of clinical & translational endocrinology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rafael Silvestre KnackHospital Israelita Albert Einstein, Sao Paulo, Brazil dr.rafaelknackhiae@gmail.com.ORCID http://orcid.org/0000-0001-8549-8618
Taliê HanadaMetropolitan University of Santos, Santos, Brazil.
Renata Silvestre KnackHospital Israelita Albert Einstein, Sao Paulo, Brazil.
Kamilla MayrMetropolitan University of Santos, Santos, Brazil.
Hospital Israelita Albert Einstein · BRUniversidade Metropolitana de Santos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious diseases have long been considered one of the triggers for autoimmune and autoinflammatory diseases. Since the appearance of the new coronavirus in December 2019 in the city of Wuhan, China, there have been many reports suggesting that infection with coronavirus 2 (SARS-CoV-2) precedes the appearance of several autoimmune and autoinflammatory diseases. We describe a case report of a patient who was infected with the SARS-CoV-2 virus and later developed a picture of Hashimoto's thyroiditis.

Indexed as

COVID-19Hashimoto DiseaseChinaHumansSARS-CoV-2COVID-19endocrine system

Identifiers

PMID34373245
PMCPMC8354276
OpenAlexW3188818319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.